Edition:
United States

GlycoMimetics Inc (GLYC.OQ)

GLYC.OQ on NASDAQ Stock Exchange Global Market

11.73USD
12:35pm EST
Change (% chg)

$-0.16 (-1.35%)
Prev Close
$11.89
Open
$11.87
Day's High
$12.19
Day's Low
$11.66
Volume
30,581
Avg. Vol
108,881
52-wk High
$26.01
52-wk Low
$8.29

Chart for

About

GlycoMimetics, Inc. is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs. The Company operates through the identification and development of glycomimetic compounds segment. The Company is developing its lead drug candidate, GMI-1070 (Rivipansel), for the treatment... (more)

Overall

Beta: 2.73
Market Cap(Mil.): $512.90
Shares Outstanding(Mil.): 43.14
Dividend: --
Yield (%): --

Financials

  GLYC.OQ Industry Sector
P/E (TTM): -- 86.30 36.06
EPS (TTM): -1.13 -- --
ROI: -26.60 10.31 12.72
ROE: -26.71 10.60 13.74

Earnings vs. Estimates